Literature DB >> 17532632

The role of molecular size in ligand efficiency.

Charles H Reynolds1, Scott D Bembenek, Brett A Tounge.   

Abstract

Ligand efficiency is a simple metric for assessing whether a ligand derives its potency from optimal fit with the protein target or simply by virtue of making many contacts. Comparison of protein-ligand binding affinities for over 8000 ligands with 28 protein targets shows conclusively that the average ligand binding affinities are not linear with molecular size. It is therefore important to scale ligand efficiencies by the size of the ligand, particularly where small ligands (e.g., fragments) are involved. We propose a simple 'fit quality' metric that removes this dependence.

Mesh:

Substances:

Year:  2007        PMID: 17532632     DOI: 10.1016/j.bmcl.2007.05.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  36 in total

1.  Hot spot analysis for driving the development of hits into leads in fragment-based drug discovery.

Authors:  David R Hall; Chi Ho Ngan; Brandon S Zerbe; Dima Kozakov; Sandor Vajda
Journal:  J Chem Inf Model       Date:  2011-12-15       Impact factor: 4.956

2.  S-Farnesyl-Thiopropionic Acid (FTPA) Triazoles as Potent Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase.

Authors:  Joel A Bergman; Kalub Hahne; Jiao Song; Christine A Hrycyna; Richard A Gibbs
Journal:  ACS Med Chem Lett       Date:  2011-11-28       Impact factor: 4.345

3.  Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.

Authors:  Gautier Moroy; Elyette Martin; Annick Dejaegere; Roland H Stote
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

4.  Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor.

Authors:  Arpita Agrawal; César Augusto F de Oliveira; Yuhui Cheng; Jennifer A Jacobsen; J Andrew McCammon; Seth M Cohen
Journal:  J Med Chem       Date:  2009-02-26       Impact factor: 7.446

5.  Assessing the lipophilicity of fragments and early hits.

Authors:  Paul N Mortenson; Christopher W Murray
Journal:  J Comput Aided Mol Des       Date:  2011-05-26       Impact factor: 3.686

6.  Homology models of mouse and rat estrogen receptor-α ligand-binding domain created by in silico mutagenesis of a human template: molecular docking with 17ß-estradiol, diethylstilbestrol, and paraben analogs.

Authors:  Thomas L Gonzalez; James M Rae; Justin A Colacino; Rudy J Richardson
Journal:  Comput Toxicol       Date:  2018-11-28

7.  Quantum mechanical pairwise decomposition analysis of protein kinase B inhibitors: validating a new tool for guiding drug design.

Authors:  Xiaohua Zhang; Alan C Gibbs; Charles H Reynolds; Martin B Peters; Lance M Westerhoff
Journal:  J Chem Inf Model       Date:  2010-04-26       Impact factor: 4.956

Review 8.  Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

Review 9.  The role of ligand efficiency metrics in drug discovery.

Authors:  Andrew L Hopkins; György M Keserü; Paul D Leeson; David C Rees; Charles H Reynolds
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

10.  The promiscuous protein binding ability of erythrosine B studied by metachromasy (metachromasia).

Authors:  Lakshmi Ganesan; Peter Buchwald
Journal:  J Mol Recognit       Date:  2013-04       Impact factor: 2.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.